Cargando…

Following a discussion with members of the CERN-Bologna Group R406 - search for a new particles using ISR, we wish to state that the two muon experiment (ISRC-73-9) proposed for the SFM is compatible with R406

Detalles Bibliográficos
Autor principal:	CERN. Geneva. ISR Experiments Committee
Lenguaje:	eng
Publicado:	1973
Materias:	Detectors and Experimental Techniques
Acceso en línea:	http://cds.cern.ch/record/1002955

Ejemplares similares

Memorandum: Experiment R406
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1974)

R406 - control room
por: CERN PhotoLab
Publicado: (1975)

Request for running time for experiment R406 in 1974 and 1975
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1973)

Memorandum: 90$^{0}$ set up for R-406
por: Zichichi, A
Publicado: (1975)

Progress report of the ISRC
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1971)

Identification of SYK inhibitor, R406 as a novel senolytic agent
por: Cho, Hyun-Ji, et al.
Publicado: (2020)

Clinical Pharmacokinetics and Pharmacodynamics of Fostamatinib and Its Active Moiety R406
por: Matsukane, Ryosuke, et al.
Publicado: (2022)

Revisions of the "proposal for a large 4 $\pi$-detector to investigate multibody events at ISR CERN-ISRC-72-32"
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1973)

Documents received by ISRC during 1973
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1973)

Documents received by ISRC during 1972
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1973)

Addendum to proposed experiment CERN-ISRC-6916, 17
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1969)

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
por: Sato, Chihiro, et al.
Publicado: (2021)

Long-term survival in 406 males with breast cancer.
por: Adami, H. O., et al.
Publicado: (1985)

Pharmacokinetics and Efficacy of the Spleen Tyrosine Kinase Inhibitor R406 after Ocular Delivery for Retinoblastoma
por: Pritchard, Eleanor M., et al.
Publicado: (2014)

Young‐onset frontotemporal dementia in a homozygous tau R406W mutation carrier
por: Ng, Adeline S. L., et al.
Publicado: (2015)

In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib
por: Rolf, Michael G, et al.
Publicado: (2015)

Addendum to the request to study $\Phi$ - and $\Lambda$ - production, CERN-ISRC-74-34
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1974)

406 Living Review of World Trade Center Health Effects
por: Katruska, Alan, et al.
Publicado: (2023)

FRI406 Maternal Biomarkers Of Adiposity And Stress For Preterm Birth
por: Mayne, Gabriella, et al.
Publicado: (2023)

미군 제406의학종합연구소의 위상과 역할, 1946-1953(†)
Publicado: (2022)

Evidence for a Common Founder and Clinical Characteristics of Japanese Families with the MAPT R406W Mutation
por: Ikeuchi, Takeshi, et al.
Publicado: (2011)

The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance
por: Duran, George E., et al.
Publicado: (2019)

Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?
por: Saha, Sovan, et al.
Publicado: (2022)

Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum
por: Gossye, Helena, et al.
Publicado: (2022)

Support for proposed quark hunt (ISRC-71-8) and results of preliminary test at the PS
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1971)

Letter of intent to the ISRC: Study of light ion interactions with the SFM detector
por: Bell, W, et al.
Publicado: (1981)

Addendum to proposal (CERN-ISRC-69-8) to measure $p^+p^ \to p^+ n^+ \pi^{+}$
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1969)

Addendum to proposal (CERN-ISRC-69-8) to measure $p^+p^- \to p^ + n^+ \pi^{+}$
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1969)

Combined layout of quark search and heavy resonance search (ISRC-70-18) in I4
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1971)

Decisions of the ISRC against the Bologna-CERN group: an example of scientific injustice
por: Zichichi, A
Publicado: (1971)

RES2/406: Making Complex Datasets Available over the Web
por: Walker, N
Publicado: (1999)

THU406 24-hydroxylase Deficiency, A Rare Cause Of Hypercalcemia
por: Hodge, Jordesha, et al.
Publicado: (2023)

Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patients
por: Rajkumar, S, et al.
Publicado: (2023)

Letter of intent to the ISRC: a study of inelastic P-$\alpha$-collisions with the SFM
por: Faessler, M A
Publicado: (1979)

The frontotemporal dementia mutation R406W blocks tau’s interaction with the membrane in an annexin A2–dependent manner
por: Gauthier-Kemper, Anne, et al.
Publicado: (2011)

Pathological Progression Induced by the Frontotemporal Dementia-Associated R406W Tau Mutation in Patient-Derived iPSCs
por: Nakamura, Mari, et al.
Publicado: (2019)

Memorandum: ISR run time for SFM program
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1981)

406. Cloning Antibodies Against Kawasaki Disease from Acute Plasmablast Responses
por: Baron, Sarah, et al.
Publicado: (2019)

Addendum to document CERN-ISRC-73-27
por: Groves, E
Publicado: (1973)

Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review
por: Ygland, Emil, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_00odljqe771ffqtnqjq71f6tb9